The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before ge

Vivus (VVUS) is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based

Seeing shades of blue? On November 14, the whole globe will be seeing them, too. The International Diabetes Federation (IDF) is hosting World Diabetes Day and asking that monuments around the globe b

It’s a small shot in the arm, but it could mean big money for pharmaceutical companies around the world. With flu season upon us and swine flu threatening to reach pandemic proportions, Big Pha

It’s becoming common knowledge that commodity-based exchange-traded funds (ETFs) have some basic design flaws that not only affect their performance but also have an impact on the very futures

There are 10 things that smart leaders do to help them cope -- but those very actions could mess up their companies, careers, and lives. "Everybody here has the ability to do anything I do and m

All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights and analysis in real-time on Minyanville's Buzz & Ban

A strong IPO market is good news for private equity, and the new issues market will remain strong into next year, the president and chief operating officer of Blackstone Group (BX) believes.“We

Last night Bloomberg printed an article about Fannie Mae (FNM) and Freddie Mac (FRE). Here are the lowlights:1. There were 2.6 million defaults on residential mortgages in the first nine months of 20

Cher sure got her wish last week, clocks (and stocks) both going back. Daylight -- and assorted other -- Savings disappeared as the Dow ended October with its worst one day point decline si